@heparegenix.com
HepaRegeniX is developing drugs for treating acute and chronic liver diseases.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
About
Description
HepaRegeniX GmbH is a clinical stage company focused on developing innovative therapies for acute and chronic liver diseases. With a foundation in groundbreaking research from the University Hospital Tubingen in Germany, HepaRegeniX has successfully discovered and developed several drug candidates that target a unique molecular regulator called Mitogen-Activated Protein Kinase Kinase 4 (MKK4). By unlocking the regenerative capacity of hepatocytes, even in severely diseased livers, HepaRegeniX's therapies offer a new therapeutic concept for the treatment of liver diseases.
Their first candidate, HRX-0215, has recently entered clinical development, marking an important milestone in their mission to address the significant unmet medical need in liver diseases. Backed by esteemed investors like the Boehringer Ingelheim Venture Fund (BIVF), Novo Holdings A/S, Coparion, High-Tech Gruenderfonds, and Ascenion GmbH, HepaRegeniX is poised for continued success in the field. To learn more about their groundbreaking research, career opportunities, or to get in touch with them, visit their website or contact them directly via phone or email.
HepaRegeniX is committed to making a significant impact in the field of liver disease treatment
Company Type
Privately Held
Company Size
2-10
Year Founded
2017
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories